SummerHaven Investment Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-35,554
Closed -$630K – 263
2023
Q2
$630K Sell
35,554
-8,042
-18% -$136K 0.4% 129
2023
Q1
$776K Buy
43,596
+964
+2% +$18K 0.45% 122
2022
Q4
$835K Buy
42,632
+529
+1% +$10.7K 0.5% 90
2022
Q3
$803K Buy
+42,103
New +$852K 0.56% 46
2021
Q3
– Sell
-32,621
Closed -$917K – 288
2021
Q2
$917K Buy
32,621
+815
+3% +$21.7K 0.52% 75
2021
Q1
$700K Hold
31,806
– – 0.43% 126
2020
Q4
$594K Buy
+31,806
New +$572K 0.46% 117

Other funds holding TBI

SummerHaven Investment Management's TBI Position: Q3 2023 in Review

SummerHaven Investment Management sold out of Trueblue (TBI) in Q3 2023, closing a stake of 35,554 shares — an estimated $630K sold.

SummerHaven Investment Management first reported a position in TBI in Q4 2020 and held it in 7 quarters. The position peaked at $917K in Q2 2021. 144 funds tracked by Wall St. Rank hold TBI as of Q3 2023.

  • SummerHaven Investment Management reported no remaining Trueblue position as of Q3 2023 after selling out during the quarter.
  • SummerHaven Investment Management sold 35,554 Trueblue shares in Q3 2023, an estimated $630K.
  • SummerHaven Investment Management first reported a position in Trueblue in Q4 2020 and held it in 7 quarters.
  • SummerHaven Investment Management's Trueblue position peaked at $917K in Q2 2021.
  • 144 funds tracked by Wall St. Rank held Trueblue as of Q3 2023.

Based on SummerHaven Investment Management's 13F filing for Q3 2023, filed 13 Oct 2023.